You haven't searched anything yet.
About Civica
Civica is a 501(c)(4) social welfare organization established in 2018 by health systems and philanthropies to reduce chronic generic drug shortages and related high prices in the United States. Civica is led by an experienced team of healthcare and pharmaceutical industry leaders.
Today, more than 55 health systems have joined Civica. They represent over 1,500 hospitals and one-third of all U.S. hospital beds. Civica has also begun to supply the U.S. Department of Veteran’s Affairs, the U.S. Department of Defense and the U.S. Strategic National Stockpile of essential medicines.
Civica recently announced plans to expand its mission, via a unit called CivicaScript, to into the outpatient pharmacy space and to manufacture and distribute insulins that, once approved, will be available to people with diabetes at significantly lower prices than insulins currently on the market. The availability of Civica’s affordable insulins, beginning in 2024, will benefit people with diabetes who have been forced to choose between life sustaining medicines and living expenses, particularly those uninsured or underinsured who often pay the most out of pocket for their medications.
Civica’s mission is to ensure that quality generic medications are accessible and affordable to everyone. Since established, the #1 Policy for the Civica team has been “Do What Is in the Best Interest of Patients.” Civica’s manufacturing facility in Petersburg, Virginia, is the future home of affordable insulin and essential sterile injectable medicines. The facility is currently in late-stage construction and hiring for the site is well-underway.
To find out more about how Civica’s innovative model is directly impacting patient care, click here to read a summary from the New England Journal of Medicine. (https://catalyst.nejm.org/doi/full/10.1056/CAT.21.0189)
To learn more about Civica’s plans to bring affordable insulin to Americans living with diabetes, click here to read an article in BioSpace.
(https://www.biospace.com/article/civica-is-rallying-leaders-to-make-insulin-affordable-by-2024-/)
Position Summary
Advanced level Manufacturing Technician position with the responsibility to weigh and dispense active pharmaceutical ingredients (API) and excipients in preparation of compounding. Compound bulk solutions for the filling operations and operate packaging equipment.
Essential Duties and Responsibilities
Minimum Qualifications (Knowledge, Skills, and Abilities)
1st Shift: 7am to 3:30pm
Full Time
$40k-54k (estimate)
04/24/2024
06/23/2024
civicarx.org
Lehi, UT
<25
The job skills required for Manufacturing Tech I (321) - 1st Shift include Packaging, Standard Operating Procedures, Futures, Good Manufacturing Practice, etc. Having related job skills and expertise will give you an advantage when applying to be a Manufacturing Tech I (321) - 1st Shift. That makes you unique and can impact how much salary you can get paid. Below are job openings related to skills required by Manufacturing Tech I (321) - 1st Shift. Select any job title you are interested in and start to search job requirements.
The following is the career advancement route for Manufacturing Tech I (321) - 1st Shift positions, which can be used as a reference in future career path planning. As a Manufacturing Tech I (321) - 1st Shift, it can be promoted into senior positions as a Manufacturing Technician II that are expected to handle more key tasks, people in this role will get a higher salary paid than an ordinary Manufacturing Tech I (321) - 1st Shift. You can explore the career advancement for a Manufacturing Tech I (321) - 1st Shift below and select your interested title to get hiring information.